In this condition, we decided to treat the patient with ECT because a review of the international literature showed that it had good results and was indicated for all relapsing tumors of the skin regardless of the dimensions and histological types.
Previous review publications have advocated ECT to be a relatively safe during pregnancy (Anderson and Reti 2009; Miller 1994; Reyes et al. 2011; Saatcioglu and Tomruk 2011).
There is uncertainty as to the magnitude and persistence of retrograde amnesia following ECT [ 12], though a systematic review suggested that 29 55 % of patients reported persistent and often distressing loss of important past memories after ECT [ 13].
In Karmacharya and colleagues' review of cases [ 1], ECT was uniformly beneficial in cases of delirious mania.
The previous held opinion by the Miller (1994) review concerning potential complications from ECT during pregnancy to be minimized by improved technique, are also questioned by our results.
The same review also reports a partial positive ECT response for pregnant women together with a very low number (N= 11) of ECT-related fetal or neonatal abnormalities.
We aimed to review published work for the efficacy and safety of electroconvulsive therapy (ECT) with simulated ECT, ECT versus pharmacotherapy, and different forms of ECT for patients with depressive illness.
In many reviews, delirium could be treated with ECT [ 17, 24] and the most lethal form of catatonia, malignant catatonia, also meets the criteria of delirium [ 29].
In an ongoing systematic review of cognitive impairment following electroconvulsive therapy (ECT) to treat major depressive disorder, 78 published articles passed title and abstract and full-text screening.
Others regard it as a safe treatment that is underused [ 11], and a systematic review found no persistent cognitive deficits after ECT [ 12].
We are also searching the references of published reviews and health technology assessments related to ECT and cognition.
